GLAXOSMITHKLINE

glaxosmithkline-logo

GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people. GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach ... focuses on science related to the immune system, the use of genetics, and advanced technologies. The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries. The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.
#SimilarOrganizations #People #Financial #Event #Website #More

GLAXOSMITHKLINE

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1929-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.gsk.com

Total Employee:
10001+

Status:
Active

Contact:
2157517173

Email Addresses:
[email protected]

Total Funding:
25.51 M USD

Technology used in webpage:
Google Font API LetsEncrypt Font Awesome Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Organization Schema IPv6 JsDelivr


Similar Organizations

bayer-logo

Bayer

Bayer offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology.

not_available_image

GSK - Cephalosporins Antibiotics Business

GlaxoSmithKline's Cephalosporins based brands composed of Zinnat, Zinacef and Fortum

jaber-ibn-hayyan-pharmaceutical-logo

Jaber Ibn Hayyan Pharmaceutical

Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.

selvita-logo

Selvita

Selvita is a drug discovery company engaged in the research and development of breakthrough therapies in the area of oncology.


Current Advisors List

simon-dingemans_image

Simon Dingemans Board of Directors @ GlaxoSmithKline
Board_member

philip-hampton_image

Philip Hampton Chairman of the Board of Directors @ GlaxoSmithKline
Board_member
2015-05-07

sharon-o-kane_image

Sharon O Kane Expert Advisor to the Stevenage Bioscience Catalyst Facility @ GlaxoSmithKline
Advisor

stacey-cartwright_image

Stacey Cartwright Board of Directors @ GlaxoSmithKline
Board_member

moncef-slaoui_image

Moncef Slaoui Board of Directors @ GlaxoSmithKline
Board_member

daniel-podolsky_image

Daniel Podolsky Member of Board of Directors @ GlaxoSmithKline
Board_member

lynn-elsenhans_image

Lynn Elsenhans Board of Directors @ GlaxoSmithKline
Board_member

vindi-banga_image

Vindi Banga Board of Directors @ GlaxoSmithKline
Board_member

Current Employees Featured

emma-walmsley_image

Emma Walmsley
Emma Walmsley CEO @ GlaxoSmithKline
CEO

iain-mackay_image

Iain Mackay
Iain Mackay Chief Financial Officer @ GlaxoSmithKline
Chief Financial Officer

brian-mcnamara_image

Brian McNamara
Brian McNamara CEO GSK Consumer Healthcare @ GlaxoSmithKline
CEO GSK Consumer Healthcare
2016-01-01

hal-barron_image

Hal Barron
Hal Barron President Research And Development @ GlaxoSmithKline
President Research And Development
2018-01-01

roger-connor_image

Roger Connor
Roger Connor President, Global Vaccines @ GlaxoSmithKline
President, Global Vaccines

not_available_image

Olivier Le Bussy
Olivier Le Bussy R&D Scientist @ GlaxoSmithKline
R&D Scientist

pascal-ducheix_image

Pascal Ducheix
Pascal Ducheix Digital Media Procurement Director @ GlaxoSmithKline
Digital Media Procurement Director

katrin-haram_image

Katrin Haram
Katrin Haram Sales and Marketing Coordinator @ GlaxoSmithKline
Sales and Marketing Coordinator

mark-g-miller_image

Mark G. Miller
Mark G. Miller Team Member @ GlaxoSmithKline
Team Member

love-oyeniran_image

Love Oyeniran
Love Oyeniran RPA Tech Security and Risk Consultant @ GlaxoSmithKline
RPA Tech Security and Risk Consultant
2018-09-01

Founder


not_available_image

John Smith

nicholas-babaian_image

Nicholas Babaian

Stock Details


Company's stock symbol is NYSE:GSK

Acquisitions List

Date Company Article Price
2022-05-31 Affinivax Affinivax acquired by GlaxoSmithKline 2.1 B USD
2022-04-13 Sierra Oncology Sierra Oncology acquired by GlaxoSmithKline 1.9 B USD
2019-09-12 Sitari Pharmaceuticals Sitari Pharmaceuticals acquired by GlaxoSmithKline N/A
2018-12-03 TESARO TESARO acquired by GlaxoSmithKline 5.1 B USD
2015-02-11 GlycoVaxyn GlycoVaxyn acquired by GlaxoSmithKline 190 M USD
2013-05-29 Okairos Okairos acquired by GlaxoSmithKline 325 M USD
2012-08-03 Human Genome Sciences Human Genome Sciences acquired by GlaxoSmithKline 3 B USD
2012-05-15 CellZome CellZome acquired by GlaxoSmithKline 61 M GBP
2010-12-13 MaxiNutrition MaxiNutrition acquired by GlaxoSmithKline 162 M GBP
2010-12-07 Nanjing MeiRui Pharma Co., Ltd. Nanjing MeiRui Pharma Co., Ltd. acquired by GlaxoSmithKline 70 M USD

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - GlaxoSmithKline

carb-x_image

CARB-X

CARB-X investment in Grant - GlaxoSmithKline

Investments List

Date Company Article Money raised
2022-03-23 LifeMine Therapeutics GlaxoSmithKline investment in Series C - LifeMine Therapeutics 175 M USD
2020-12-18 Adrestia Therapeutics GlaxoSmithKline investment in Series A - Adrestia Therapeutics 172 M GBP
2020-07-20 CureVac GlaxoSmithKline investment in Corporate Round - CureVac 130 M GBP
2020-04-07 Vir Biotechnology GlaxoSmithKline investment in Post-IPO Equity - Vir Biotechnology 250 M USD
2019-09-18 SetPoint Medical GlaxoSmithKline investment in Venture Round - SetPoint Medical 15.7 M USD
2019-04-01 SpringWorks Therapeutics GlaxoSmithKline investment in Series B - SpringWorks Therapeutics 125 M USD
2018-07-24 23andMe GlaxoSmithKline investment in Corporate Round - 23andMe 300 M USD
2016-02-02 Spero Therapeutics GlaxoSmithKline investment in Series B - Spero Therapeutics 30 M USD
2015-11-04 Atreca GlaxoSmithKline investment in Series A - Atreca 56 M USD
2015-06-23 Gladius Pharmaceuticals GlaxoSmithKline investment in Series A - Gladius Pharmaceuticals 4.1 M CAD

Newest Events participated

london-tech-week-2019_event_image Participated in London Tech Week 2019 on 2019-06-10 as sponsor

gsk-immunohack_event_image Participated in GSK ImmunoHack on 2018-07-13 as organizer

redefining-early-stage-investments-resi-conference-toronto_event_image Participated in Redefining Early Stage Investments (RESI) Conference @ Toronto on 2018-04-10 as sponsor

orphandrug-congress-usa-2017_event_image Participated in OrphanDrug Congress USA 2017 on 2017-04-19 as sponsor

china-dental-show-csa-annual-meeting_event_image Participated in China Dental Show & CSA Annual Meeting on 2015-09-24 as exhibitor

eap-congress-and-mastercourse-2015_event_image Participated in EAP Congress and MasterCourse 2015 on 2015-09-17 as sponsor

north-carolina-science-festival_event_image Participated in North Carolina Science Festival on 2015-04-10 as sponsor

big-bang-fair-2015_event_image Participated in Big Bang Fair 2015 on 2015-03-11 as sponsor

Official Site Inspections

http://www.gsk.com Semrush global rank: 78.15 K Semrush visits lastest month: 1.37 M

  • Host name: 221.83.117.34.bc.googleusercontent.com
  • IP address: 34.117.83.221
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "GlaxoSmithKline" on Search Engine

dfkcompany.com © 2022. All rights reserved